Dr. Michael Fountain, D.O.
What this data tells you about Dr. Fountain
Dr. Michael Fountain is an urology physician in Tavares, FL, with 17 years in practice. Based on federal Medicare data, Dr. Fountain performed 9,899 Medicare services across 2,139 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fountain received a total of $207 from 5 pharmaceutical and/or device companies across 7 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fountain is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 3,651 | $2 | $9 |
| Botox injection, per unit | 3,200 | $5 | $19 |
| Automated urinalysis | 482 | $2 | $7 |
| Office visit, established patient (20-29 min) | 279 | $62 | $269 |
| Office visit, established patient (30-39 min) | 279 | $89 | $381 |
| Diagnostic exam of bladder and urethra using an endoscope | 274 | $177 | $708 |
| Bladder ultrasound after voiding | 186 | $8 | $32 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 148 | $131 | $565 |
| Drug injection, under skin or into muscle | 105 | $11 | $42 |
| Simple insertion of temporary bladder tube | 103 | $43 | $182 |
| Simple change of bladder tube | 96 | $70 | $288 |
| Instillation of anti-cancer drug into bladder | 94 | $68 | $262 |
| New patient office visit (45-59 min) | 87 | $116 | $499 |
| Telephone medical discussion with physician, 5-10 minutes | 85 | $34 | $165 |
| Injection, garamycin, gentamicin, up to 80 mg | 77 | $2 | $8 |
| Simple bladder irrigation and/or instillation | 74 | $58 | $226 |
| Initial hospital admission, moderate complexity | 74 | $104 | $395 |
| Urinalysis, manual | 71 | $3 | $11 |
| Insertion of stent in ureter using an endoscope | 57 | $115 | $557 |
| New patient office visit (30-44 min) | 48 | $77 | $336 |
| Initial hospital admission, high complexity | 39 | $133 | $525 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 33 | $248 | $947 |
| Biopsy of prostate gland | 32 | $99 | $394 |
| Ultrasound scan of pelvic region through rectum | 32 | $23 | $97 |
| Telephone medical discussion with physician, 11-20 minutes | 32 | $58 | $269 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 31 | $327 | $1,296 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 30 | $584 | $2,211 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 25 | $18 | $68 |
| Hospital follow-up visit, low complexity | 25 | $41 | $152 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 22 | $304 | $1,157 |
| Hospital follow-up visit, moderate complexity | 22 | $64 | $239 |
| Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm | 21 | $176 | $742 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 21 | $26 | $99 |
| Imaging of urinary tract following injection of a contrast agent | 20 | $19 | $74 |
| Dilation of urethra using an endoscope | 19 | $255 | $969 |
| Shock wave crushing of kidney stones | 13 | $475 | $1,799 |
| Crushing of stone of ureter using an endoscope | 12 | $314 | $1,232 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Fountain is a mixed practice specialist, with above-average Medicare volume (top 11% in FL), and low-engagement industry engagement, with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Fountain experienced with bcg treatment for bladder cancer?
Does Dr. Fountain receive payments from pharmaceutical companies?
How do Dr. Fountain's costs compare to other urology physicians in Tavares?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology